Anne Q. Reuwer

ORCID: 0000-0003-3016-5749
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Growth Hormone and Insulin-like Growth Factors
  • Pituitary Gland Disorders and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Systemic Lupus Erythematosus Research
  • Orthopedic Infections and Treatments
  • Hormonal Regulation and Hypertension
  • Peroxisome Proliferator-Activated Receptors
  • HIV/AIDS drug development and treatment
  • Cytokine Signaling Pathways and Interactions
  • Cardiovascular Disease and Adiposity
  • Orthopaedic implants and arthroplasty
  • Cholesterol and Lipid Metabolism
  • Health Literacy and Information Accessibility
  • Polyomavirus and related diseases
  • Platelet Disorders and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Endometrial and Cervical Cancer Treatments
  • Lipid metabolism and disorders
  • Autoimmune and Inflammatory Disorders Research
  • Ovarian function and disorders
  • Full-Duplex Wireless Communications
  • Blood Coagulation and Thrombosis Mechanisms
  • Hepatitis C virus research
  • Diet and metabolism studies
  • Cardiovascular Issues in Pregnancy

Elisabeth-TweeSteden Ziekenhuis
2017-2018

Amsterdam UMC Location University of Amsterdam
2009-2016

University of Amsterdam
2009-2016

Amphia Ziekenhuis
2015

Université Paris Cité
2014

Délégation Paris 5
2014

Waterlandziekenhuis
2011-2012

Tergooi
2011-2012

University of Insubria
2010

Leiden University Medical Center
2010

Colette Smit Anders Boyd Bart Rijnders Thijs van de Laar Eliane M.S. Leyten and 95 more Wouter F.W. Bierman Kees Brinkman Mark Claassen Jan den Hollander Anne Boerekamps Astrid M. Newsum Janke Schinkel Maria Prins Joop E. Arends Eline Op de Coul Marc van der Valk Peter Reiss Marc van der Valk Suzanne E. Geerlings Abraham Goorhuis Joppe W. Hovius B. Lempkes F.J.B. Nellen T. van der Poll Jan M. Prins Michèle van Vugt W. Joost Wiersinga F.W.M.N. Wit Marlies van Duinen J. van Eden A. Hazenberg A M H van Hes F J J Pijnappel S Smalhout Annouschka M. Weijsenfeld Suzanne Jurriaans Nicole Back Hans L. Zaaijer B. Berkhout Marion Cornelissen C. Schinkel Katja C. Wolthers Edgar J.G. Peters Michiel A. van Agtmael Reshma Autar Marije K. Bomers Kim Sigaloff M. Heitmuller Liedewij Laan C. Wim Ang Robin van Houdt Marcel Jonges Maarten van den Berge Arjan Stegeman S. Baas L. Hage de Looff A. G. M. Buiting Anne Q. Reuwer Jacobien Veenemans Bas Wintermans M.J.H. Pronk Heidi S. M. Ammerlaan D. N. J. van den Bersselaar E. S. de Munnik Birgit Deiman A R Jansz Volkher Scharnhorst Jeroen H. T. Tjhie M.C.A. Wegdam Arne van Eeden Jeannine F. Nellen W. Brokking L. Elsenburg H. Nobel C. Schinkel M.E.E. van Kasteren Marvin A. H. Berrevoets Annemarie E. Brouwer Andrew L. Adams R. van Erve B.A.F.M. de Kruijf-van de Wiel S. Keelan-Phaf B. van de Ven A. G. M. Buiting J.L. Murck T.E.M.S. de Vries-Sluijs Hannelore I. Bax Eric C. M. Van Gorp N. C. de Jong-Peltenburg Martim Melo Els van Nood Jan Nouwen Bart Rijnders Casper Rokx Carolina A. M. Schurink Lennert Slobbe Annelies Verbon N. Bassant J. E. A. van Beek M. Vriesde

10.1016/s2352-3018(20)30301-5 article EN The Lancet HIV 2020-12-22

Abstract Prolactin is best known as the polypeptide anterior pituitary hormone, which regulates development of mammary gland. However, it became clear over last decade that prolactin contributes to a broad range pathologies, including breast cancer. also involved in angiogenesis via release pro‐angiogenic factors by leukocytes and epithelial cells. whether influences endothelial cells, there are functional consequences prolactin‐induced signalling perspective angiogenesis, remains so far...

10.1111/j.1582-4934.2011.01499.x article EN cc-by Journal of Cellular and Molecular Medicine 2011-12-02

The aim of this trial was to determine whether obese patients benefit from treatment with rimonabant in terms progression carotid atherosclerosis. Rimonabant, a selective cannabinoid-1 receptor blocker, reduces body weight and improves cardiometabolic risk factors who are obese.A prospective, double-blind, placebo-controlled (Atherosclerosis Underlying Development assessed by Intima-media Thickness On Rimonabant (AUDITOR)) randomised 661 abdominal obesity metabolic syndrome or placebo for 30...

10.1136/hrt.2011.223446 article EN Heart 2011-05-24

The aim of this verification study was to compare the QuantiFERON®-TB Gold Plus (QFT-Plus) In Tube (QFT-GIT). new QFT-Plus test contains an extra antigen tube which, according manufacturer additionally elicits a CD8+ T-cell response above CD4+ response. We assessed value in detecting recent latent tuberculosis infections.Between May 2015 and December 2016, 1031 subjects underwent QFT-GIT test. Overall agreement between both tests performance for different indications and/or immune states...

10.1016/j.tube.2017.11.014 article EN cc-by-nc-nd Tuberculosis 2017-11-29

Prolactin is increasingly recognized to play a stimulatory role in the inflammatory response. Because inflammation considered of crucial importance development atherosclerosis, we aimed evaluate whether prolactin levels are associated with occurrence coronary artery disease (CAD).We performed nested case-control study prospective EPIC-Norfolk cohort. Cases were apparently healthy men and women, aged 45 79 years, who developed fatal or nonfatal CAD (n=882). Controls remained free (n=1490)....

10.1161/circgenetics.109.853572 article EN Circulation Cardiovascular Genetics 2009-06-24

Atherosclerotic vascular disease is the consequence of a chronic inflammatory process, and prolactin has been shown to be component response. Additionally, recent studies indicate that contributes an atherogenic phenotype. We hypothesized this may result direct effect on atherogenesis through activation receptor. Human carotid atherosclerotic plaques were obtained from patients by endarteriectomies. The mRNA receptor, but not prolactin, was detected in these quantitative real-time PCR. In...

10.1677/joe-10-0076 article EN Journal of Endocrinology 2010-11-10

Prolactin (PRL) is a lactation-inducing hormone with immunomodulatory properties and found at elevated levels in the serum of patients RA other rheumatic diseases. The PRL receptor (PRLR) has been shown to be expressed by macrophages atherosclerotic plaques. aim this study was examine PRLR expression synovial its role regulation macrophage activation.Serum monomeric 23 kDa were measured 119 using fluoroimmunometric assay. assessed tissue 91 RA, 15 PsA 8 OA immunohistochemistry digital image...

10.1093/rheumatology/kew316 article EN cc-by-nc Lara D. Veeken 2016-09-10

Summary Platelets play an important role in the development of plaque formation and events after rupture atherosclerotic plaque, leading to atherothrombosis. Multiple hormones, either excess or when deficient, are involved atherothrombotic disease, but, which extent such hormones affect platelet function, is still controversial. It was objective this study assess ability pituitary hormone prolactin functions. Venous blood collected from six healthy males. Platelet activation studied by (i)...

10.1160/th08-12-0801 article EN Thrombosis and Haemostasis 2009-01-01

Objective— Several acquired risk factors for venous thrombosis (VT) are associated with high prolactin levels. Our goal was to investigate VT different levels of prolactin. Methods and Results— We used data a case-control study on leg vein conducted between September 1999 August 2006 at the Academic Medical Center, Amsterdam, Netherlands. Prolactin assessed in 187 cases (mean age, 57 years; range, 19 90) 374 gender-matched controls 18 93). Odds ratios 95% CI were estimated based several...

10.1161/atvbaha.110.209569 article EN Arteriosclerosis Thrombosis and Vascular Biology 2010-12-17

Atherothrombosis is a multifactorial process, governed by an interaction between the vessel wall, hemodynamic factors and systemic atherothrombotic risk factors. Recent in vitro, human ex vivo animal studies have implicated hormone prolactin as mediator. To address this issue, we evaluated anatomy function of various microvascular beds well plasma atherothrombosis markers patients with elevated levels. In pilot study, involving 10 prolactinoma control subjects, sidestream dark field (SDF)...

10.1007/s11102-011-0353-9 article EN cc-by-nc Pituitary 2011-10-12

The pituitary-derived hormone prolactin has been suggested to stimulate the development of atherosclerosis and cardiovascular disease through its effects on metabolism inflammation. In this study, we aimed challenge hypothesis that inhibition function may beneficially affect burden. Hereto, atherosclerosis-susceptible LDL receptor (Ldlr) knockout mice were transplanted with bone marrow from transgenic expressing pure antagonist Del1-9-G129R-hPRL or their non-transgenic littermates as...

10.1530/joe-14-0343 article EN Journal of Endocrinology 2014-07-25

Prolactin may contribute to an atherogenic phenotype. Furthermore, previous studies have shown that prolactin levels increase in situations of acute stress and inflammation. We therefore aimed investigate the relationship between prolactin, inflammation patients with myocardial infarction. performed a case-control study 40 infarction 39 controls, aged 41–84 years. Blood for assessment high sensitive C-reactive protein (hsCRP) was drawn at inclusion, is, during phase event, 2–3 weeks later....

10.1055/s-0030-1265221 article EN Hormone and Metabolic Research 2010-09-30

Evaluation of 16S PCR in addition to the standard culture improve pathogen detection rate clinical specimens.Microbiological and direct was performed on specimens from suspected prosthetic joint infection patients (cohort-1) tissues fluids other normally sterile body sites (cohort-2). Based microbiological data, for both methods assessed, assuming no superiority either or culture. In cohort-1, 469 were obtained. Culture positive 170 (36·2%) specimens, detected 70 (41·2%) those pathogens....

10.1111/jam.14156 article EN Journal of Applied Microbiology 2018-11-15

Antipsychotic drugs have been shown to modulate the expression of ATP-binding cassette transporter A1 (ABCA1), a key factor in anti-atherogenic reverse cholesterol transport process, vitro. Here we evaluated potential typical antipsychotic drug haloperidol efflux function macrophages vitro and their susceptibility atherosclerosis vivo.Thioglycollate-elicited peritoneal were used for studies. Hyperlipidaemic low-density lipoprotein (LDL) receptor knockout mice implanted with...

10.1111/bph.13067 article EN British Journal of Pharmacology 2015-01-09

<h3>Background and objective</h3> Rheumatoid arthritis (RA) is a rheumatic disease mainly affecting women. Prolactin (PRL) sex hormone, which apart from inducing lactation, has also immunomodulatory properties. High prolactin levels are associated with an increased activity postpartum some studies have shown that bromocriptin, decreasing levels, improves clinical of patients RA. Furthermore, hyperprolactinemia observed in 6% RA compared to 3% the normal population. Recently, receptor (PRLR),...

10.1136/annrheumdis-2011-201238.1 article EN Annals of the Rheumatic Diseases 2012-02-01

Cardiovascular diseases (CVDs) account for approximately 30% of all deaths globally. The most important cause CVD is atherothrombosis, in other words, narrowing the arteries as a result deposition cholesterol and lipoid substances within arterial wall. Several endocrine disorders have been linked to this pathological state. Recent clinical experimental studies suggested that prolactin, pleiotropic pituitary hormone, may potentially contribute CVD, either through direct modulation local...

10.1586/eem.12.23 article EN Expert Review of Endocrinology & Metabolism 2012-05-01
Coming Soon ...